Chemoinformaics analysis of DELTA-9,12,15-OCTADECATRIENIC-ACID
| Molecular Weight | 402.575 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.271 | nRig | 15 |
| Exact Molecular Weight | 402.277 | nRing | 2 |
| Solubility: LogS | -5.459 | nHRing | 0 |
| Solubility: LogP | 5.665 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 70.2961 |
| nHD | 1 | BPOL | 41.5939 |
| QED | 0.332 |
| Synth | 4.564 |
| Natural Product Likeliness | 3.039 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.687 |
| MDCK | 0.0000202 |
| BBB | 0.092 |
| PPB | 0.944154 |
| VDSS | 0.775 |
| FU | 0.0466628 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.123 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.765 |
| CYP2c9-inh | 0.531 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.229 |
| CYP3a4-inh | 0.284 |
| CYP3a4-sub | 0.182 |
| CL | 12.703 |
| T12 | 0.229 |
| hERG | 0.002 |
| Ames | 0.005 |
| ROA | 0.007 |
| SkinSen | 0.846 |
| Carcinogencity | 0.121 |
| EI | 0.147 |
| Respiratory | 0.944 |
| NR-Aromatase | 0.063 |
| Antiviral | Yes |
| Prediction | 0.580794 |